UNICA IRIS Institutional Research Information System

COCCO, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 493.491
NA - Nord America 25.806
AS - Asia 11.825
SA - Sud America 1.871
AF - Africa 299
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 25
Totale 533.346
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 486.166
US - Stati Uniti d'America 25.368
SG - Singapore 4.682
CN - Cina 3.821
BR - Brasile 1.434
SE - Svezia 1.274
UA - Ucraina 1.264
NL - Olanda 1.241
VN - Vietnam 1.101
DE - Germania 895
FI - Finlandia 714
GB - Regno Unito 673
FR - Francia 606
HK - Hong Kong 426
BD - Bangladesh 364
IN - India 262
CA - Canada 245
KR - Corea 185
AR - Argentina 153
TR - Turchia 119
IQ - Iraq 115
JP - Giappone 109
RU - Federazione Russa 102
MX - Messico 100
ZA - Sudafrica 95
AT - Austria 81
ES - Italia 78
PL - Polonia 74
PK - Pakistan 71
ID - Indonesia 65
MA - Marocco 64
EC - Ecuador 62
CO - Colombia 59
UZ - Uzbekistan 56
VE - Venezuela 54
BE - Belgio 53
PH - Filippine 51
IR - Iran 49
SA - Arabia Saudita 49
CL - Cile 37
CZ - Repubblica Ceca 35
MY - Malesia 34
IE - Irlanda 33
IL - Israele 30
AE - Emirati Arabi Uniti 26
LT - Lituania 26
EU - Europa 25
AU - Australia 24
AZ - Azerbaigian 24
JO - Giordania 24
KE - Kenya 24
TN - Tunisia 24
EG - Egitto 23
DZ - Algeria 22
JM - Giamaica 22
NP - Nepal 20
GR - Grecia 19
RO - Romania 19
UY - Uruguay 19
PY - Paraguay 18
CH - Svizzera 17
CR - Costa Rica 16
PE - Perù 16
TH - Thailandia 16
BO - Bolivia 15
OM - Oman 15
AL - Albania 14
KZ - Kazakistan 14
PS - Palestinian Territory 14
PT - Portogallo 14
TW - Taiwan 14
DK - Danimarca 11
HU - Ungheria 11
DO - Repubblica Dominicana 10
HR - Croazia 10
LB - Libano 10
RS - Serbia 10
CI - Costa d'Avorio 9
ET - Etiopia 9
KG - Kirghizistan 9
KW - Kuwait 9
GT - Guatemala 8
PA - Panama 8
BG - Bulgaria 7
EE - Estonia 7
MD - Moldavia 7
NG - Nigeria 6
NO - Norvegia 6
SN - Senegal 6
BH - Bahrain 5
CY - Cipro 5
GE - Georgia 5
LA - Repubblica Popolare Democratica del Laos 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
SV - El Salvador 5
GY - Guiana 4
PR - Porto Rico 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
Totale 533.277
Salva come PNG Salva come JPEG
Città #
Cagliari 473.309
Uta 10.670
Ashburn 2.461
Singapore 2.372
Fairfield 2.335
Woodbridge 1.768
San Jose 1.404
Dallas 1.237
Chandler 1.197
Houston 1.125
Boardman 1.104
Amsterdam 1.102
Wilmington 983
Seattle 942
Ann Arbor 829
Cambridge 779
Nyköping 710
Beijing 700
Jacksonville 592
Los Angeles 588
Helsinki 466
New York 403
Hong Kong 385
Dearborn 365
Chicago 356
Council Bluffs 343
Lauterbourg 331
The Dalles 322
Ho Chi Minh City 313
Santa Clara 308
Munich 291
Nanjing 287
Shanghai 276
Boston 259
Hefei 257
Buffalo 235
Hanoi 235
Milan 194
Seoul 174
Rome 172
Salt Lake City 144
San Diego 139
Guangzhou 131
São Paulo 124
Dong Ket 122
London 112
Atlanta 103
Toronto 102
Shenyang 100
Nanchang 96
Norwalk 96
Orem 95
Redwood City 90
Redondo Beach 83
Tokyo 82
Elk Grove Village 81
Jiaxing 80
Frankfurt am Main 76
Washington 73
Hebei 71
Sassari 71
Tampa 71
Brooklyn 70
Phoenix 65
Changsha 63
Tianjin 61
Warsaw 57
Montreal 56
Da Nang 54
Verona 54
Johannesburg 53
Nuremberg 53
Tashkent 49
Denver 46
Baghdad 45
Stockholm 45
Columbus 44
Rio de Janeiro 43
Vienna 43
Jinan 42
Shenzhen 40
Chennai 39
Hangzhou 39
Istanbul 39
Miami 39
Sterling 39
Mexico City 38
Detroit 37
Naples 37
Turku 37
Brussels 36
Mountain View 36
Zhengzhou 36
Düsseldorf 34
Haiphong 33
Dublin 32
San Francisco 32
Manchester 31
Curitiba 30
Wuhan 30
Totale 515.978
Salva come PNG Salva come JPEG
Nome #
Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation 6.162
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.983
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 5.248
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.945
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.585
EFFECTS OF SIX MONTHS TRAINING ON PHYSICAL CAPACITY AND METABOREFLEX ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS. 4.501
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.491
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia 4.405
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.310
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.223
Quantitative assessment of the effects of 6 months of adapted physical activity on gait in people with multiple sclerosis: a randomized controlled trial 4.218
Overexpression of the cytokine BAFF and autoimmunity risk 4.130
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 4.050
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 4.024
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.939
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia 3.912
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.896
Clinical Assessment of Gait in Individuals with Multiple Sclerosis Using Wearable Inertial Sensors: Comparison with Patient-Based Measure 3.846
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.843
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.826
Effectiveness and Limitations of Unsupervised Home-Based Balance Rehabilitation with Nintendo Wii in People with Multiple Sclerosis 3.806
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.732
The Required Coefficient of Friction for evaluating gait alterations in people with Multiple Sclerosis during gait 3.713
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.670
Walking improvements with nabiximols in patients with multiple sclerosis 3.653
Texting while walking differently alters gait patterns in people with multiple sclerosis and healthy individuals 3.624
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.621
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.613
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.596
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.592
A genetic association study of two genes linked to neurodegeneration in a Sardinian multiple sclerosis population: The TARDBP Ala382Thr mutation and C9orf72 expansion 3.515
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.444
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.414
Impact of the media on future hope in multiple sclerosis 3.392
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.320
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.314
Multiple Sclerosis and environmental factors. 3.299
Are static and functional balance abilities related in individuals with Multiple Sclerosis? 3.297
Combining HLA-DRB1-DQB1 and Mycobacterium Avium Subspecies Paratubercolosis (MAP) antibodies in Sardinian multiple sclerosis patients: associated or independent risk factors? 3.294
Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation 3.244
Oral agents in multiple sclerosis 3.215
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 3.212
Influence of treatments in multiple sclerosis disability: a cohort study 3.188
‘Timed up and go’ and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis 3.168
Top-down proteomic profiling of human saliva in multiple sclerosis patients 3.144
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.122
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis 3.107
Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity 3.099
Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study 3.073
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 3.064
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 3.051
Smoothness of gait, but not spatio-temporal parameters, are altered in early stages of Multiple Sclerosis 3.002
Refining the connection between gait and cognition: training the body to improve the brain 2.989
Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis 2.986
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis 2.982
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.980
Relationship between gait initiation and disability in individuals affected by multiple sclerosis 2.965
Effect of 6 months of adapted physical activity on gait patterns in individuals with multiple sclerosis: a three-dimensional quantitative analysis 2.955
Validation of the Arm Profile Score in assessing upper limb functional impairments in people with multiple sclerosis 2.922
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.881
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.877
Hourly trends of physical activity in people with Multiple Sclerosis 2.857
Effect of spasticity on kinematics of gait and muscular activation in people with multiple sclerosis 2.819
Do gait patterns differ in men and women with multiple sclerosis? 2.805
Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study 2.729
Postural adaptation during a Nintendo Wii balance training 2.676
Perception of risk and shared decision making process in multiple sclerosis 2.657
Pregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: A monocentre assessment 2.647
Smoothness of gait detects early alterations of walking in persons with multiple sclerosis without disability 2.643
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1 H-NMR Spectroscopy 2.628
Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy 2.616
Are static and dynamic balance abilities correlated in people with Multiple Sclerosis? 2.604
The relationships between physical activity, self-efficacy, and quality of life in people with multiple sclerosis 2.600
Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia 2.573
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.561
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 2.538
Geoepidemiology of Multiple Sclerosis: the environmental factors. 2.487
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.452
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patient 2.412
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.341
The cohort of the multiple sclerosis center of Cagliari 2.336
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.333
Balance patterns in people with multiple sclerosis using Nintendo Wii 2.319
Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement 2.306
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.294
Induction and escalation therapies in multiple sclerosis 2.288
Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-α2-chain gene: a chance association or a novel phenotype? 2.276
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.261
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 2.249
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.238
Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis 2.217
Aberrant splicing in the LMNA gene caused by a novel mutation on the polypyrimidine tract of intron 5 2.206
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 2.105
Does focal inflammation have an impact on cognition in multiple sclerosis? An MRI study 2.105
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.075
Tardbp ala382thr mutation in multiple sclerosis: A possible role in brain atrophy 2.067
Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population 2.058
Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population 2.056
Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin 2.038
Novel Characterization of Gait Impairments in People with Multiple Sclerosis by Means of the Gait Profile Score 2.028
Totale 316.172
Salva come PNG Salva come JPEG
Categoria #
all - tutte 680.242
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 680.242
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.237 0 0 0 0 0 0 0 0 0 0 0 4.237
2021/202225.919 3.270 1.763 1.115 2.039 2.209 1.580 1.217 1.264 2.468 2.858 3.383 2.753
2022/202336.235 3.108 5.156 5.038 3.231 3.069 3.597 1.763 2.760 2.009 2.109 2.761 1.634
2023/202438.874 2.396 1.901 1.510 2.537 3.741 6.434 5.206 3.347 1.961 2.893 3.507 3.441
2024/202598.907 28.032 28.966 11.450 8.286 4.316 4.788 6.787 483 1.114 1.990 1.689 1.006
2025/202626.359 1.758 1.093 2.417 2.373 1.798 1.840 5.513 2.191 1.870 2.380 1.916 1.210
Totale 534.715